Financials
Income statement
| Fiscal date | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|
| Total reported revenue | 1.0B | 1.0B | 1.4B | 1.0B |
| Cost of revenue | 681.4M | 637.4M | 888.0M | 652.9M |
| Gross profit | 365.2M | 371.7M | 544.4M | 373.8M |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 553.7M | 533.0M | 535.2M | 525.7M |
| Other operating expenses | — | — | — | — |
| Operating income | -221.8M | -192.9M | -24.3M | -185.0M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 16.3M | 12.0M | 10.8M | 13.6M |
| Other income expense | 2K | 1K | 553K | 204.7M |
| Pretax income | -238.1M | -204.8M | -34.6M | 6.1M |
| Tax provision | 350K | 191K | -3.9M | 1.3M |
| Net income | -238.5M | -205.0M | -30.7M | 4.7M |
| Basic EPS | -8.0 | -7.0 | -1.1 | 0.2 |
| Diluted EPS | -8.0 | -7.0 | -1.1 | 0.2 |
| Basic average shares | 29.6M | 29.4M | 29.2M | 29.2M |
| Diluted average shares | 29.6M | 29.4M | 29.2M | 29.3M |
| EBITDA | -187.7M | -160.4M | 10.0M | -151.4M |
| Net income from continuing op. | -238.5M | -205.0M | -30.7M | 4.7M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |